IP Library › Granted Patent US 12,474,272
Granted Patent B2
US 12,474,272 · App. 17/425,243 · Granted Nov 18, 2025

Optical cavity surface bioconjunction using lipid membranes for label free, ultrasensitive detection of biomolecules

Inventors: Phuong-Diem Nguyen (Tucson, AZ); Judith Su (Tucson, AZ); Adley Gin (Tucson, AZ); Erol Ozgur (Tucson, AZ)
Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
G01N21/7746
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,474,272
App. No.
17/425,243
Granted
Nov 18, 2025
Kind
B2
Abstract

An optical system includes an optical resonant cavity, an optical source, an optical detector, and a signal processing circuit. The optical source is arranged to provide a source beam of light to be at least partially coupled into the optical resonant cavity. The optical detector is arranged to detect light from the source beam of light after the source beam of light has coupled into the optical resonant cavity to provide a detection signal. The signal processing circuit is configured to communicate with the optical detector to receive the detection signal. The optical resonant cavity has a bioconjugatable lipid membrane on a surface thereof. The bioconjugatable lipid membrane is functionalized to capture a specific biomolecule, and the signal processing circuit is further configured to determine a presence of the specific biomolecule when captured by the functionalized bioconjugatable lipid membrane based on processing the detection signal.

Claims (18)

1 . An optical system for detecting specific biomolecules, comprising:

an optical resonant cavity;

a lipid membrane formed on at least a portion of a surface of said optical resonant cavity;

an optical source arranged to provide a source beam of light to be at least partially coupled into said optical resonant cavity;

an optical detector arranged to detect light from said source beam of light after said source beam of light has coupled into said optical resonant cavity to provide a detection signal; and

a signal processing circuit configured to communicate with said optical detector to receive said detection signal,

wherein said signal processing circuit is further configured to process said detection signal to determine at least a resonance wavelength of said optical resonant cavity during operation.

2 . The optical system according to claim 1 , wherein said optical resonant cavity and said lipid membrane have a quality factor (Q) of at least 10 4 .

3 . The optical system according to claim 1 , wherein said optical resonant cavity is a microtoroid optical resonant cavity and said optical source comprises an optical waveguide configured to couple light into said microtoroid optical resonant cavity by evanescent fields.

4 . The optical system according to claim 1 , wherein said lipid membrane is a stabilized lipid membrane.

5 . The optical system according to claim 1 , wherein a G-protein coupled receptor (GPCR) is incorporated in the lipid membrane.

6 . The optical system according to claim 1 , wherein said optical resonant cavity comprises silica.

7 . The optical system according to claim 1 , wherein said lipid membrane comprises at least one of soybean phosphatidylcholine, egg phosphatidylcholine, or synthetic phosphatidylcholine (DOPC, DOPE, POPC).

8 . The optical system according to claim 1 , wherein said lipid membrane is functionalized with a capture agent for detecting a biomarker.

9 . The optical system according to claim 8 , wherein said capture agent is at least one of an antibody, an aptamer, complementary DNA, or a protein receptor for detecting a biomarker.

10 . The optical system according to claim 8 , wherein said capture agent is specific for capturing Amyloid-β.

11 . The optical system according to claim 8 , wherein said signal processing circuit is further configured to determine spectral components of said detection signal.

12 . The optical system according to claim 1 , wherein said lipid membrane is a lipid bilayer.

Assignments (2)
CONFIRMATORY LICENSE Recorded Dec 6, 2023
From: UNIVERSITY OF ARIZONA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 065791/0593 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2022
From: NGUYEN, PHUONG-DIEM; SU, JUDITH; GIN, ADLEY; OZGUR, EROL
To: ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
Reel/Frame 061499/0449 →
Continuity (2)
Provisional Application 62796835 · Jan 25, 2019
Related Publication 20220091044A1 · Mar 24, 2022
References Cited (27)
US 20060211093A1 · Sligar et al. · 2006 [cited by applicant]
US 20090226887A1 · Brisson · 2009 [cited by applicant]
US 20130295688A1 · Bailey · 2013 [cited by examiner]
US 20150338346A1 · Chou et al. · 2015 [cited by applicant]
US 20170120218A1 · Saavedra et al. · 2017 [cited by applicant]
US 20170322207A1 · Su · 2017 [cited by applicant]
International Search Report and Written Opinion issued in PCT/US2020/015204 on May 21, 2020. [cited by applicant]
Su et al., “Label-free detection of single nanoparticles and biological molecules using microtoroid optical resonators”, Light: Science and Applications, (2016), vol. 5, (6 pages). [cited by applicant]
Vollmer et al., “Whispering-gallery-mode biosensing: label-free detection down to single molecules”, Nature Methods, (Jul. 2008), vol. 5, pp. 591-596. [cited by applicant]
Repovsky et al., “Formation Mechanism of a Silane-PVA/PVAc Complex Film on a Glass Fiber Surface”, Chem Phys Chem, (2013), vol. 14, pp. 3569-3580. [cited by applicant]
Howarter et al., “Optimization of Silica Silanization by 3-Aminopropyltriethoxysilane”, Langmuir (2006), vol. 22, No. 26, pp. 11142-11147. [cited by applicant]
Kulkarni et al., “Turning the hydrophobic properties of silica particles by surface silanization using mixed self-assembled monolayers”, Colloid and Interface Science, (2008), vol. 318, 372-379. [cited by applicant]
Eske et al., “Characterization of SiO2 surface treatments using AFM, contact angles and a novel dewpoint technique”, Colloids and Surface A: Physicochemical and Engineering Aspects, (1999), vol. 154, pp. 33-51. [cited by applicant]
Rodriguez-Franco et al., “Effect of the transducer's surface pre-treatment on SPR aptasensor development”, Sensors Actuators B: Chemical, (2014), vol. 191, pp. 634-642. [cited by applicant]
Puu et al., “Planar lipid bilayers on solid supports from liposomes—factors of importance for kinetics and stability”, BBA Biomembranes, (1997), vol. 1327, pp. 149-161. [cited by applicant]
Andersson et al., “Cell adhesion on supported lipid bulayers”, J Biomed Mater Res A, 64A, (2003), pp. 622-629. [cited by applicant]
Tegoulia et al. “Surface Properties, Fibrinogen Adsorption, and Cellular Interactions of a Novel Phosphorylcholine-Containing Self-Assembled Monolayer on Gold”, Langmuir, (2001), vol. 17, pp. 4396-4404. [cited by applicant]
Hartman et al., “Cluster size regulated protein sorting in the immunological synapse”, P Natl Acad Sci USA, (Aug. 4, 2009), vol. 106, No. 31, pp. 12729-12734. [cited by applicant]
Yoo et al., “A highly sensitive plasma-based amyloid-beta detection system through medium-changing and noise cancellation system for early diagnosis of the Alzheimer's disease”, Scientific Reports, (Aug. 21, 2017), vol.… [cited by applicant]
Rama et al., “Competitive electrochemical immunosensor for amyloid-beta 1-42 detection based on gold nanostructured Screen-Printed Carbon Electrodes”, Sensors Actuators B: Chemical, (2014), vol. 201, pp. 567-571. [cited by applicant]
Sun et al., “Real-time detection of lipid bilayer assembly and detergent-initiated solubilization using optical cavities”, Appl. Phys. Lett. (Feb. 17, 2015), vol. 106, (5 pages). [cited by applicant]
Fischer, “Amine Coupling Through EDC/NHS: A Practical Approach”, M.J., Methods Mol. Biol. (2010), vol. 627, pp. 55-73. [cited by applicant]
Englund et al. “Sensitive ELISA detection of amyloid-beta protofibrils in biological samples”, J. Neurochem, (2007), vol. 103, pp. 334-345. [cited by applicant]
Van Helmond et al., “Characterisation of two antibodies to oligomeric alpha-beta and their use in ELISAs on human brain tissue homogenates”, J Neurosci. Methods, (2009), vol. 176, pp. 206-212. [cited by applicant]
Santos et al., “Detection of Amyloid-beta Oligomers in Human Cerebrospinal Fluid by Flow Cytometry and Fluorescence Resonance Energy Transfer”, J Alzheimers. Dis., (2007), vol. 11, pp. 117-125. [cited by applicant]
Santos et al., “A Method for the Detection of Amyloid-beta1-40, Amyloid-beta1-42 and Amyloid-beta Oligomers in Blood Using Magnetic Beads in Combination with Flow Cytometry and its Application in the Diagnostics of Alzh… [cited by applicant]
Peng et al., “Mobile Lipid Bilayers on Gold Surfaces through Structure-Induced Lipid Vesicle Rupture”, Langmuir (Mar. 6, 2015), vol. 31, pp. 3904-3911. [cited by applicant]